Epidemiology and Prevention of Renal Cell Carcinoma
Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi et al. · Cancers · 2022
With 400,000 diagnosed and 180,000 deaths in 2020, renal cell carcinoma (RCC) accounts for 2.4% of all cancer diagnoses worldwide. The highest disease burden developed countries, primarily in Europe and North America. Incidence is projected to increase in the future as more countries shift to Western lifestyles. Risk factors for RCC include fixed factors such as gender, age, and hereditary diseases, as well as intervening factors such as smoking, obesity, hypertension, diabetes, diet and alcohol, and occupational exposure. Intervening factors in primary prevention, understanding of congenital risk factors and the establishment of early diagnostic tools are important for RCC. This review will discuss RCC epidemiology, risk factors, and biomarkers involved in reducing incidence and improving survival.
Cited by 150 works. doi:10.3390/cancers14164059 Open-access PDF
Authors
References
- Cancer statistics, 2017
- Cancer Statistics, 2021
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- Comprehensive molecular characterization of clear cell renal cell carcinoma
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- Long Noncoding RNA and Cancer: A New Paradigm
- Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
- Epidemiology of Renal Cell Carcinoma
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- Renal Tumors in the Birt-Hogg-Dubé Syndrome